Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New program aims to break down barriers to ADHD care for kids

NCT ID NCT05796427

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 35 times

Summary

This study tests a program called START, which provides 6 sessions of education and support to families of children aged 6-12 with ADHD. The goal is to help families overcome stigma and other barriers to get their child into treatment. 106 participants will be randomly assigned to START or a pamphlet. Researchers will measure whether the program improves treatment use and daily functioning.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADHD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Ann & Robert H. Lurie Children's Hospital

    Chicago, Illinois, 60611, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

behavioral intervention (START program)

What this could lead to

If successful, this program could help more families get their children with ADHD into treatment and improve daily life at home and school.

What could go wrong

This is a small, early-stage trial with 106 participants. The program is behavioral, not a drug, so effects may be modest and may not apply to all families.

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.